Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:34 AM EDT
154.00quote price arrow down-4.00 (-2.53%)
Volume
226,747
52 week range
115.61 - 464.85
Loading...
  • Open157.00
  • Day High158.51
  • Day Low153.59
  • Prev Close158.00
  • 52 Week High464.85
  • 52 Week High Date09/10/21
  • 52 Week Low115.61
  • 52 Week Low Date06/13/22

Key Stats

  • Market Cap60.245B
  • Shares Out391.20M
  • 10 Day Average Volume4.66M
  • Dividend-
  • Dividend Yield-
  • Beta1.57
  • YTD % Change-37.79

KEY STATS

  • Open157.00
  • Day High158.51
  • Day Low153.59
  • Prev Close158.00
  • 52 Week High464.85
  • 52 Week High Date09/10/21
  • 52 Week Low115.61
  • 52 Week Low Date06/13/22
  • Market Cap60.245B
  • Shares Out391.20M
  • 10 Day Average Volume4.66M
  • Dividend-
  • Dividend Yield-
  • Beta1.57
  • YTD % Change-37.79

RATIOS/PROFITABILITY

  • EPS (TTM)32.80
  • P/E (TTM)4.69
  • Fwd P/E (NTM)7.82
  • EBITDA (TTM)15.945B
  • ROE (TTM)113.86%
  • Revenue (TTM)22.995B
  • Gross Margin (TTM)82.29%
  • Net Margin (TTM)61.12%
  • Debt To Equity (MRQ)4.24%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO3:0103:01
Three Stock Lunch: Disney, Moderna and Exxon Mobil

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...
Noubar Afeyan Ph.D.
Non-Executive Independent Chairman of the Board, Co-Founder
Stephane Bancel
Chief Executive Officer, Director
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technical Operations and Quality Officer
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
REGN
Regeneron Pharmaceuticals Inc
633.02-3.32-0.52%
BNTX
BioNTech SE
149.40-2.64-1.74%
BIIB
Biogen Inc
215.81-1.77-0.81%
ILMN
Illumina Inc
211.90-1.12-0.53%
ALNY
Alnylam Pharmaceuticals Inc
224.00+0.87+0.39%